Germany’s Merck has long grappled with its name in the crucial U.S. drug market, where unaffiliated group Merck & Co. holds rights to the designation. But now it is facing a more existential predicament: Will it even be a pharmaceuticals company in coming years?
from WSJ.com: US Business http://ift.tt/1BIwZyI
via IFTTT
No comments:
Post a Comment